Latest News in the pharma Industry

All

Potential first-in-class treatment reaches significant milestone

Potential first-in-class treatment reaches significant milestone

2 Mar 2020

The US Food and Drug Administration (FDA) accepts for review Pfizer and Eli Lilly's Biologics License Application (BLA) for tanezumab — a non-opioid treatment for patients with chronic pain due to moderate-to-severe osteoarthritis.

Read more 
New advanced LC system delivers productivity, precision and compliance

New advanced LC system delivers productivity, precision and compliance

2 Mar 2020

The Vanquish Core HPLC System maximizes the delivery of precise results with simple, seamless method transfer.

Read more 
Trump and pharma execs to discuss progress on COVID-19 cure

Trump and pharma execs to discuss progress on COVID-19 cure

2 Mar 2020

The White House task force and the US President will meet drug makers this afternoon to discuss "progress on a vaccine and cure".

Read more 
New plant for IGH Flavours & Technology

New plant for IGH Flavours & Technology

2 Mar 2020

IGH Flavours & Technology from Disproquima group, inaugurated last November its new headquarters and manufacturing plant in Murcia, Spain.

Read more 
FDA reports first coronavirus-related drug shortage

FDA reports first coronavirus-related drug shortage

28 Feb 2020

The US Food and Drug Administration has reported the first case of a pharmaceutical drug shortage directly related to the global coronavirus (COVID-19) outbreak that is threatening to reach pandemic status.

Read more 
CPhI Japan 2020 Postponed

CPhI Japan 2020 Postponed

27 Feb 2020

Rescheduling will ensure all stakeholders can take part in a successful exhibition and conference.

Read more 
Merck KGaA,  AMCM/EOS co-operate in 3D printing of tablets

Merck KGaA, AMCM/EOS co-operate in 3D printing of tablets

27 Feb 2020

A cooperation agreement between German pharma firm Merck KGaA and additive manufacturing specialist AMCM on 3D printing of tablets could eventually lead to scalable active pharmaceutical ingredient (API) formulation and faster, cheaper production, the ...

Read more 
BIA Separations signs agreement to commercialise novel elution technology

BIA Separations signs agreement to commercialise novel elution technology

26 Feb 2020

Agreement gives BIA Separations access to proprietary technology to better preserve integrity, infectivity and potency of immunoaffinity-purified viral vectors for gene therapy.

Read more 
Perrigo, Catalent announce FDA approval of generic version of Teva’s ProAir HFA inhaler

Perrigo, Catalent announce FDA approval of generic version of Teva’s ProAir HFA inhaler

26 Feb 2020

A generic version of Teva’s ProAir HFA inhaler for asthma and chronic obstructive pulmonary disease has finally been approved by the US Food and Drug Administration, the partners in the project, Perrigo and Catalent, announced Tuesday.

Read more 
WuXi Biologics and Vir Biotechnology announce mAbs development collaboration to treat COVID-19

WuXi Biologics and Vir Biotechnology announce mAbs development collaboration to treat COVID-19

26 Feb 2020

Chinese CDMO WuXi Biologics has linked up with San Francisco biotech firm Vir Biotechnology to develop and manufacture human monoclonal antibodies (mAbs) to potentially treat coronavirus disease (COVID-19), the two firms said Tuesday.

Read more 
Accomplished scientific leader and GSK veteran, Dean Edney joins Sai Life Sciences

Accomplished scientific leader and GSK veteran, Dean Edney joins Sai Life Sciences

25 Feb 2020

Sai Life Sciences, today announced the appointment of Dr. Dean Edney as Senior Vice President and Global Head of Process Research & Development.

Read more 
Non-hormonal treatment for menopausal hot flashes begins clinical trials

Non-hormonal treatment for menopausal hot flashes begins clinical trials

25 Feb 2020

The study will evaluate the efficacy of SJX-653 in reducing the frequency and severity of VMS due to menopause, as well as improving measures of sleep and quality of life.

Read more